BiotechTube
Home/Tulavi Therapeutics/Josh Vose, MD, MBA
JV

Josh Vose, MD, MBA

Chief Executive Officer

Tulavi Therapeutics

Therapeutic Areas

Neuroscience

Tulavi Therapeutics Pipeline

DrugIndicationPhase
allay Hydrogel CapReduction of risk of symptomatic neuroma formation after peripheral nerve transectionCommercial

Leadership Team at Tulavi Therapeutics

FK
Fred Khosravi
Chairman & Co-Founder
View full Tulavi Therapeutics profile